Stephan Dietrich A
Insider CIK 1774588 · NBSE President and CEO, Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| NBSE NeuBase Therapeutics, Inc. | M Exercise deriv | 2023-08-02 | 2023-08-04 | 93,234 | — | $0 | 0 | SEC↗ |
| NBSE NeuBase Therapeutics, Inc. | M Exercise | 2023-08-02 | 2023-08-04 | 93,234 | $0.02 | $1.9K | 93,234 | SEC↗ |
| NBSE NeuBase Therapeutics, Inc. | A Award | 2023-03-16 | 2023-03-17 | 153,000 | — | $0 | 153,000 | SEC↗ |
| NBSE NeuBase Therapeutics, Inc. | M Exercise deriv | 2023-02-13 | 2023-02-15 | 655,000 | — | $0 | 1,864,680 | SEC↗ |
| NBSE NeuBase Therapeutics, Inc. | M Exercise | 2023-02-13 | 2023-02-15 | 655,000 | — | $0 | 1,471,775 | SEC↗ |
| NBSE NeuBase Therapeutics, Inc. | M Exercise deriv | 2022-09-28 | 2022-09-30 | 750,000 | — | $0 | 2,519,680 | SEC↗ |
| NBSE NeuBase Therapeutics, Inc. | M Exercise | 2022-09-28 | 2022-09-30 | 750,000 | — | $0 | 816,775 | SEC↗ |
| NBSE NeuBase Therapeutics, Inc. | A Award deriv | 2022-01-24 | 2022-01-25 | 306,000 | — | $0 | 306,000 | SEC↗ |
| NBSE NeuBase Therapeutics, Inc. | M Exercise deriv | 2021-12-31 | 2022-01-05 | 42,250 | — | $0 | 3,269,680 | SEC↗ |
| NBSE NeuBase Therapeutics, Inc. | M Exercise | 2021-12-31 | 2022-01-05 | 42,250 | — | $0 | 66,775 | SEC↗ |
| NBSE NeuBase Therapeutics, Inc. | P Buy | 2021-04-26 | 2021-04-27 | 12,000 | $5.00 | $60.0K | 24,525 | SEC↗ |
| NBSE NeuBase Therapeutics, Inc. | A Award deriv | 2020-12-29 | 2020-12-30 | 164,925 | — | $0 | 164,925 | SEC↗ |
| NBSE NeuBase Therapeutics, Inc. | G Gift | 2020-12-01 | 2020-12-30 | 1,273,820 | — | $0 | 1,273,819 | SEC↗ |
| NBSE NeuBase Therapeutics, Inc. | G Gift | 2020-12-01 | 2020-12-30 | 1,273,819 | — | $0 | 2,547,639 | SEC↗ |
| NBSE NeuBase Therapeutics, Inc. | G Gift | 2020-11-30 | 2020-12-30 | 1,273,819 | — | $0 | 2,547,639 | SEC↗ |
| NBSE NeuBase Therapeutics, Inc. | G Gift | 2020-11-23 | 2020-12-30 | 2,547,639 | — | $0 | 2,547,639 | SEC↗ |
| NBSE NeuBase Therapeutics, Inc. | P Buy | 2020-06-09 | 2020-06-10 | 1,275 | $7.73 | $9.9K | 12,525 | SEC↗ |
| NBSE NeuBase Therapeutics, Inc. | P Buy | 2020-05-21 | 2020-05-26 | 1,250 | $8.09 | $10.1K | 11,250 | SEC↗ |
| NBSE NeuBase Therapeutics, Inc. | P Buy | 2020-04-30 | 2020-05-04 | 10,000 | $6.00 | $60.0K | 10,000 | SEC↗ |
| NBSE NeuBase Therapeutics, Inc. | A Award deriv | 2019-07-12 | 2019-07-16 | 3,311,930 | — | $0 | 3,311,930 | SEC↗ |
| NBSE NeuBase Therapeutics, Inc. | A Award | 2019-07-12 | 2019-07-16 | 2,547,639 | — | $0 | 2,547,639 | SEC↗ |